Concerns grow over rising drug costs as Trump threatens pharma tariffs

Breakdown

• The Trump administration is considering tariffs on pharmaceutical imports, potentially increasing costs by up to 250 percent.
• Experts warn that tariffs could worsen drug affordability and lead to shortages, especially for cancer patients. 18s
• Brand name drugs in the US already cost significantly more than in other developed countries. 1m 1s
• The administration aims to lower drug costs by encouraging domestic manufacturing, but experts suggest alternatives like tax incentives or grants. 1m 17s
• There are concerns that tariffs could discourage investment in drug development due to market uncertainty. 1m 53s